Sunflower Pharmaceutical: Using 500 million yuan of idle funds to purchase wealth management products.

Kuwahara Pharmaceutical announced that the company had previously decided to use no more than 2 billion yuan of idle self-owned funds for cash management, with a validity period of 12 months. Recently, the company used 500 million yuan to purchase wealth management products, including 200 million yuan for the CMB Juyishengjin Series Company B Wealth Management Plan and 300 million yuan for the Xinyin Wealth Management Anyingxiang Steady Income Product No. 47, which has a holding period of two months. As of the announcement date, the company's cash management amount that has not yet matured is 168 million yuan.